Vardaan Biotech Sets Stage for ₹90 Crore+ IPO
Vardaan Biotech Limited has taken a significant step by re-filing its Draft Red Herring Prospectus for a public offering on the BSE and NSE Mainboard platforms. This offering, structured as a book-built issue, involves 3,50,00,000 shares, aiming for a total value exceeding ₹90 crore.
Legal Expertise by Legacy Law Offices
The reputable Legacy Law Offices has been enlisted to provide legal advice to Vardaan Biotech for this IPO. Additionally, the firm has extended its expertise to the Co-Book Running Lead Managers, Interactive Financial Services Ltd and Jajodia Equity Advisors Limited. The transaction was spearheaded by Surbhi Narang, a Partner at Legacy Law Offices, with the proficient support from Naman Anand (Counsel), Soma Singh (Senior Associate), and a team of skilled associates including Yukti Goel, Anushka Indurkar, Geetika Joshi, Meghna Shukla, and Samiksha Gawali.
About Vardaan Biotech
Vardaan Biotech is renowned as an integrated seed company, specializing in the development, breeding, production, processing, and conditioning of agricultural seeds across various crop types. Their operations extend to the production of hybrid seeds, parental lines, breeder seeds, and foundation seeds, pivotal for commercial seed multiplication and the enhancement of seed quality.
Opportunities for Publication
For those interested in having their deals, columns, or press releases published on Bar & Bench, a simple form can be filled out here.
